No Data
No Data
No Data
Tobila Systems: Questions and answers regarding the second quarter financial results for the fiscal year ending in October 2024.
Japanese Shares Close Slightly Higher Ahead of BoJ's Rate Decision; Tobila Systems Adds 2% on Higher Fiscal H1 Profit
Tobila Systems' Fiscal H1 Profit Rises 33% on Higher Net Sales; Shares Up 3%
Investment Strategy for June 11th [today].
[FISCO selected stocks] [Material stocks] Pharmafoods <2929> 862 yen (6/10) Mainly engaged in supplement and cosmetic e-commerce. Also handles functional materials. Announced third quarter results. Cumulative operating profit was 3.266 billion yen (a 99.9% increase over the same period last year). Profit increased from 1.535 billion yen in the first half. At the same time, it strengthened advertising and publicity for new products while optimizing overall advertising and publicity expenses. Operating profit for the July 2024 period is expected to be 2.7 billion yen (a 25.2% decrease from the previous period) until the third quarter.
Pay attention to Kurazushi and PharmaF, while B Garage and Altona may be sluggish.
On the 10th of yesterday's U.S. stock market, the Dow Jones Industrial Average was up 69.05 dollars to 38,868.04, the Nasdaq Composite Index was up 59.40 points to 17,192.53, and the Chicago Nikkei 225 Futures were up 185 yen from the Osaka-Nichu ratio to 39,185 yen. The exchange rate is 1 dollar = 157.00-10 yen. In today's Tokyo market, Pharma F <2929> with a cumulative operating profit increase of 99.9% for the third quarter, Kura Sushi <2695> which upwardly revised its performance forecast for the fiscal year 2024 ending in October, and revenue and operating profit
Kura Sushi upwardly revised its operating profit to 5.5 billion yen from 2.4 billion yen on October 24th.
Kura Sushi <2695> announced a revision of its financial estimates for the fiscal year ending October 2024. The revenue has been revised upwards from 226.2 billion yen to 234.0 billion yen and the operating profit has been revised upwards from 2.4 billion yen to 5.5 billion yen, exceeding the consensus upper limit level (about 5.1 billion yen). Despite the difficult situation of rising procurement prices, labor and utility costs in domestic business, the company's strength in fair trade centered on high-quality products such as maguro and kani, and the popular character Chiikawa and theatrical versions.
No Data